Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold.

Source:http://linkedlifedata.com/resource/pubmed/id/20554729

Download in:

View as

General Info

PMID
20554729